There is growing evidence that the incidence and severity of many common neurological conditions are affected by climate ...

Younger adults are developing a severe gut disorder at increasing rates, according to a new study. There's been a troubling ...

Q3 2025 Earnings Call Transcript November 5, 2025 LivaNova PLC misses on earnings expectations. Reported EPS is $0.4855 EPS, ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for ...

LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for ...

Good day, ladies and gentlemen, and welcome to LivaNova plc Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I'd now like to ...

The deployment of Rigaku's Raman analyzers in Myanmar has significantly improved the identification of illicit chemicals, impacting regional drug interdiction.

Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology ...

Renowned neurosurgeon Dr. Mohana Rao Patibandla, Founder and Chief Neurosurgeon of Dr. Rao's Hospital, Guntur, has been featured on the cover of Time Iconic Magazine and recognized among the Top 10 ...

Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in bipolar mania enrolling patients and on track, with topline ...

The latest frontiers in neurodevelopment and brain disorders will take center stage at the 43rd Annual Meeting of the Indian Academy of Neurosciences (IAN), to be held at Kovalam, from October 29 to ...